Presented by Leora R. Cherney, PhD, BC-ANCDS, CCC-SLP
In recent years, there has been a proliferation of research targeting various aspects of aphasia treatment. These range from studies addressing the development, theoretical underpinnings and efficacy of specific treatments to more general issues such as intensity and dose that impact learning and outcomes, regardless of the treatment being administered.
This workshop describes the procedures for administering several of the newest aphasia treatment techniques, emphasizing their theoretical background and current evidence supporting their efficacy. Treatments that target impairment and activity-participation levels will be included. Practical issues such as dosage and service delivery models that improve access to and outcomes from treatment will be discussed.
At the end of this course, participants will be able to:
- Describe components related to “dose” of aphasia therapy.
- List procedures for administering at least four evidence-based aphasia treatments.
- Differentiate impairment and activity/participation level treatments.
- Explain the importance of considering social/life participation approaches in the treatment of aphasia.
This course is designed for practicing speech-language pathologists who have an intermediate to advanced level of experience with persons with apraxia of speech and aphasia.
This course is offered for .7 ASHA CEUs.
Intermediate, professional level.
Speaker disclosure information on back.
Save the Date!
May 2, 2020
8 a.m.-5 p.m.
St. Luke’s Boise Medical Center
Anderson Center, located on the 5th Floor of the South Tower
190 E. Bannock Street, Downtown Boise
Early-bird cost (ends April 1)
St. Luke’s Employees $30 | Students $30 | All Others $120
After April 1
St. Luke’s Employees $30 | Students $50 | All Others $150